Myovant Sciences INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$4.9Mgeneral payments (2019-2025)
$3,075research payments (2019-2025)
21,341clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2021 $2.2M
2022 $2.7M

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Specialties it works with most

Urology $1.3M
Obstetrics & Gynecology $1.1M
Nephrology (Internal Medicine) $715K
Gynecology $299K
Medical Oncology $177K
Hematology & Oncology $171K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Vandana Mathur Woodside, CA Nephrology (Internal Medicine) $714,487.50
David Wages South Boroulh, MA Hematology (Pathology) $105,700.00
Elliot Cazes Tampa, FL Obstetrics & Gynecology $104,892.11
Scott Sellinger Tallahassee, FL Urology $76,598.02
Daniel Saltzstein San Antonio, TX Urology $67,589.25
Daniel Canter Decatur, GA Urology $65,888.67
Jeffrey Frankel Burien, WA $65,356.99
Andrea Lukes Durham, NC Gynecology $63,833.41
Jay Cohen Plantation, FL Obstetrics & Gynecology $61,761.14
Samir Ahuja Mentor, OH Obstetrics & Gynecology $61,223.46

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.